Noted Los Angeles-based neuroscientist and media personality Dr. Kristen Willeumier launches Your Brain Health with Dr. Kristen Willeumier, a podcast series that explores the latest news and information in the burgeoning science of brain health.
Host Dr. Kristen Willeumier interviews John Spencer Ellis, an international leader in wellness coaching, personal development and fitness. ... read more
Neuroscientist Dr. Kristen Willeumier speaks with the founder of the global mental health movement, "We’re All A Little 'Crazy',” 15-year professional sports executive, Eric Kussin. ... read more
Dr. Willeumier has served as the Director of Clinical Neuroimaging Research for the Amen Clinics from
2009-2016 to help advance the research mission of exploring how brain SPECT imaging can transform
clinical practice. Together with Dr. Amen and colleagues, she led a number of high-profile clinical
research trials including investigating the long-term effects of repetitive sub-concussive impacts in NFL
football players. From her research, she focused on therapeutic approaches to rehabilitate brain
function in athletes and is currently investigating biomarkers for treatment of psychiatric disorders using
machine learning applications. Dr. Willeumier conducted her graduate research in the laboratory of
Neurophysiology at the University of California, Los Angeles and the laboratory of Neurogenetics at
Cedars-Sinai Medical Center using live cell imaging to investigate mechanisms of synaptic signaling in
Parkinson’s disease.
Dr. Willeumier received MS degrees in physiological science and neurobiology and a PhD degree in
neurobiology from the University of California, Los Angeles. She was a post-doctoral fellow in the
Department of Neurology at Cedars-Sinai Medical Center where she continued her work in the field of
neurodegenerative disease. She was the recipient of the prestigious NIH fellowship from the National
Institute of Mental Health to study the molecular mechanisms underlying Parkinson’s disease and has
presented her work at national and international scientific meetings including the Society for
Neuroscience, Gordon Conference and the World Brain Mapping Conference.
She has spoken before such prominent organizations as Maria Shriver's Move For Minds, The California
Women's Conference, the Professional Compounding Centers of America, the Society for Brain Mapping
and Therapeutics, the Academy of Regenerative Medicine, the RAAD Fest, the National Institutes of
Health, the Society for Neuroscience, the Gordon Research Conference, Stanford, USC, Thomas Jefferson
Law School, the Independent Football Veteran's Conference, the Retired NFL Congress and NFL Player's
Association meetings.
A nationally-renowned advocate for brain health, Dr. Willeumier has a passion for sharing her extensive
research on brain function and longevity. In addition to her RadioMD podcast, Dr. Willeumier is heard
on iHeartRadio with her weekly feature Your Brain Health, and is a featured guest on CNN, KING-TV
Seattle, KDVR-TV, Denver, WATN-TV Memphis, KATU-TV, Portland, Sports X Radio, Coast to Coast radio,
and magazines including Marie Claire and Swaay. Dr. Willeumier has spoken before such prominent
organizations as Maria Shriver's Move For Minds, The California Women's Conference, the Professional
Compounding Centers of America, the Society for Brain Mapping and Therapeutics, the Academy of
Regenerative Medicine, the RAAD Fest, the National Institutes of Health, the Society for Neuroscience,
the Gordon Research Conference, Stanford, USC, Thomas Jefferson Law School, the Independent
Football Veteran's Conference, the Retired NFL Congress and NFL Player's Association meetings.
Dr. Willeumier has been published in numerous peer reviewed journals including the Journal of
Neuroscience, PLOS One Neuromapping and Therapeutics, the Journal of Alzheimer’s Disease, Nature
Obesity, Minerva Psychiatrica, Brain Imaging and Behavior, the Journal of Neuropsychiatry and Clinical
Neurosciences, Advances in Mind Body Medicine, Clinical Neuropsychologist, the Journal of Psychoactive
Drugs, Open Neuroimaging Journal, Archives of Clinical Neuropsychology The Journal of Nuclear
Medicine, Nature Translational Psychiatry and The Journal of Systems and Integrated Neuroscience.